Fig. 1
From: Peripheral eosinophils and immunotherapy response in patients with recurrent or metastatic HNSCC
A-B) Levels of peripheral blood absolute eosinophil count and eosinophil percentage in patients with progressive disease (PD), stable disease (SD), and partial response (PR). C-D) Immunotherapy response type by peripheral blood absolute eosinophil count and eosinophil percentage in patients with recurrent or metastatic mucosal head and neck squamous cell carcinoma.
